FGF9 and metabolic dysfunction-associated steatohepatitis: Herein, we confirmed that the FGF9 controlled hepatic ECM accumulation in the NASH‐driven HCC model and established that FGF9 stimulates liver fibrosis and promotes the occurrence of HCC via ECM synthesis.